Tramazoline
Tramazoline is a chemical that is used in the form of tramazoline hydrochloride in nasal decongestant preparations.[1] It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.012.823 |
Chemical and physical data | |
Formula | C13H17N3 |
Molar mass | 215.300 g·mol−1 |
(what is this?) (verify) |
It was patented in 1961 and came into medical use in 1962.[2]
Brand names
Australia
- Spray-Tish[3]
- Rhinaspray
Austria
- Rhinorix
Belgium
- Rhinospray
Bulgaria
- Muconasal Plus
Czech Republic
- Muconasal Plus
Germany
- Biciron
- Ellatun
- Rhinospray
Italy
- Rinogutt
- Fexallegra® nasale (Tramazoline + Chlorpheniramine, 1 mg/ml + 3.55 mg/ml)
Romania
- Muconasal Plus (older)
- Muconasal (newer)
Russia
- Adrianol (tramazoline + phenylephrine)
- Lasolvan Rhino
Spain and Portugal
- Rhinospray
Slovakia
- Muconasal Plus
Ukraine
- Lasorin
US
- trama [4]
References
- Boehringer Ingelheim. "Spray-Tish Consumer Information". Consumer Medicines Information. MyDr.com.au. Retrieved 16 April 2011.
- Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 552. ISBN 9783527607495.
- "Spray-Tish". Consumer Information. Retrieved 16 April 2011.
- "Trama". Consumer Information. Retrieved 21 December 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.